Le Lézard
Classified in: Health
Subject: Statement

Mitsubishi International Food Ingredients, Inc. ("MIFI") Rebrands Fine Chemicals Department as MIFI Bioceuticalstm to Support Strategic Growth


Mitsubishi International Food Ingredients, Inc. ("MIFI") announced today the upcoming rebranding launch of its legacy Fine Chemicals Department as "MIFI Bioceuticalstm," effective December 1, 2022, homing in on the building and advancing a portfolio of unique pharmaceutical, biochemical, cosmetic, and other fine chemical ingredients.

The timing of its new MIFI Bioceuticalstm brand launch aligns with the business transformation that is taking place across MIFI with a fresh- and forward-looking approach to the market.

This news comes in the wake of many recent initiatives and accomplishments of the organization, including:

"The markets of biopharmaceutical, pharmaceutical, cosmetic, and other fine chemical ingredients are constantly pivoting and innovating, as are we. The new brand, MIFI Bioceuticalstm, is just the start of our new chapter as a true solutions provider in related industries," Tomoaki Masuda, President of MIFI Bioceuticalstm, states. "We will continue to evaluate and elevate our product portfolio and services to better support customers' innovations. We will be launching a new website specifically for MIFI Bioceuticalstm in early 2023. In the interim, please visit us at mifiusa.com and use the contact information below to reach the MIFI Bioceuticalstm team."

About MIFI Bioceuticalstm
As a global supply chain partner, Mitsubishi International Food Ingredients, Inc. ("MIFI") focuses on achieving excellence in sourcing and distributing food, nutritional, pharmaceutical, and cosmetic ingredients. MIFI Bioceuticalstm is the new name division of MIFI's Fine Chemicals Department, specifically engaging in pharmaceuticals, cosmetics, and other fine chemicals businesses. MIFI Bioceuticalstm vision is to "be a solution provider with unique & innovative ingredients," focusing on differentiated products and services with clear competitive advantages.


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: